Search research articles
Contact Us
Filters
Showing results (451-460 of 621) with videos related to
Page
of 63
Sort By:
Journal of Surgical Oncology
|
August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma
Mohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.
Blood
|
September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Philippe Armand, Ann Janssens, Giuseppe Gritti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Massimiliano Salati, Francesco Caputo, David Cunningham, et al.
Oncotarget
|
June 11, 2016
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
Askar Obulkasim, Bauke Ylstra, Hendrik F van Essen, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
Luca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
British Journal of Haematology
|
June 10, 2021
Are treatment response assessment maps (TRAMs) and <sup>18</sup> F-choline positron emission tomography the future of central nervous system lymphoma imaging?
Jie-Ying Kowa, Thomas Millard, Anouchka Goldman, et al.
British Journal of Haematology
|
March 21, 2020
Focal splenic lesions in indolent B-NHL: association with high grade transformation and safe percutaneous biopsy
Farheen Mir, Charlotte Wilding, Naami Mcaddy, et al.
The Lancet. Oncology
|
August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
Derek Alderson, David Cunningham, Matthew Nankivell, et al.
British Journal of Haematology
|
November 28, 2024
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waiting
Maria A V Marzolini, Wendi Qian, Laura Clifton-Hadley, et al.
Page
of 63
Search research articles
Search
Showing results (451-460 of 621) with videos related to
Sort By:
Page
of 63
Journal of Surgical Oncology
|
August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma
Mohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.
Blood
|
September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Philippe Armand, Ann Janssens, Giuseppe Gritti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Massimiliano Salati, Francesco Caputo, David Cunningham, et al.
Oncotarget
|
June 11, 2016
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
Askar Obulkasim, Bauke Ylstra, Hendrik F van Essen, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
Luca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
British Journal of Haematology
|
June 10, 2021
Are treatment response assessment maps (TRAMs) and <sup>18</sup> F-choline positron emission tomography the future of central nervous system lymphoma imaging?
Jie-Ying Kowa, Thomas Millard, Anouchka Goldman, et al.
British Journal of Haematology
|
March 21, 2020
Focal splenic lesions in indolent B-NHL: association with high grade transformation and safe percutaneous biopsy
Farheen Mir, Charlotte Wilding, Naami Mcaddy, et al.
The Lancet. Oncology
|
August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
Derek Alderson, David Cunningham, Matthew Nankivell, et al.
British Journal of Haematology
|
November 28, 2024
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waiting
Maria A V Marzolini, Wendi Qian, Laura Clifton-Hadley, et al.
Page
of 63